They have their fake offer in at 1.21, and a big bid in at 1.15. They're still hoping that the Patrick Cox newbies will be silly enough to let them get cheap stock (whether it's to cover their shorts, or to build their position).

Why in the world would anyone want to sell when we find out now that CTIX has been working secretly on the oral formulation of Kevetrin and that the animal studies are looking good? Especially with Prurisol and the Brilacidin family having done so well in the clinical trials so far.

I know I'm preaching to the choir but it just boggles the mind. I wish those newbies would find their way over here.